• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, May 13, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researchers create standardized measurement for pediatric facial palsy

Bioengineer by Bioengineer
May 9, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

CORVALLIS, Ore. – An international team of researchers, including a psychologist at Oregon State University, has developed a standardized measurement for pediatric facial palsy that will improve the care for current and future patients with the condition.

The team, which includes researchers from nine countries, published its findings Thursday in JAMA Facial Plastic Surgery.

Each year, more than a million children worldwide are diagnosed with pediatric facial palsy, a condition where there is a weakness of facial muscles on one or both sides of the face. There are a number of causes, including abnormalities in nerves at birth, trauma to the head or infections. For some children, the condition resolves with time, but others may have permanent facial palsy.

“Facial palsy profoundly impacts many aspects of a child’s life, from functional issues like eating and vision, to core psychological issues such as social communication, peer relationships and quality of life,” said Kathleen Bogart, an associate professor of psychology in the College of Liberal Arts at Oregon State and the only psychologist on the research team. “Using a standard set of measurement tools to track these outcomes after treatments will ensure that clinicians understand patient strengths and challenges while enabling them to verify what treatments are effective.”

Historically, there has been a wide range of measurement tools to evaluate treatment plans for patients with the condition, but efforts to create a universal measurement tool have been unsuccessful. Pediatric facial palsy is notoriously difficult to treat, and inconsistent use of outcome measures have hampered understanding of treatment effectiveness. A nonprofit organization called the International Consortium for Health Outcomes Measurement aimed to change that. The organization facilitated a series of seven teleconferences over nine months with a group of 21 experts, including Bogart, and patient representatives.

The result was the standard measurement tool that allows the recording of outcomes following facial palsy treatment, surgical and non-surgical, for pediatric patients.

The measurement tool takes into account a number of factors: facial appearance and movement; oral continence; speech; facial discomfort; vision and ocular symptoms; health-related quality of life; social health; and major complications from interventions. Each factor is assessed using a scientifically validated tool.

The standard measurement tool can be applied to all patients under 18 years of age who present with facial palsy of any duration. The following treatment options can be evaluated using the measurement tool: medical treatment, surgical treatment, eye protection interventions, physical therapy, occupational therapy, psychological therapy, speech therapy and botulinum toxin treatment.

The next step is for the researchers who developed the standard measurement tool to evaluate it and demonstrate it works. Then, they will encourage adoption of the measurement tool among a wider pool of providers and national regulatory bodies.

###

Media Contact
Kathleen Bogart
[email protected]

Related Journal Article

https://today.oregonstate.edu/news/researchers-create-standardized-measurement-pediatric-facial-palsy
http://dx.doi.org/10.1001/jamafacial.2019.0224

Tags: Medicine/HealthPediatrics
Share15Tweet7Share2ShareShareShare1

Related Posts

Mayo Clinic to Undergo Leadership Transition, Honoring Dr. Gianrico Farrugia’s Transformational Impact — Medicine

Mayo Clinic to Undergo Leadership Transition, Honoring Dr. Gianrico Farrugia’s Transformational Impact

May 13, 2026

Study Finds Sustained Weight Loss Possible by Transitioning from Injectable Obesity Drugs to Daily Oral Orforglipron (ATTAIN-MAINTAIN)

May 13, 2026

Weight Loss Maintained Seven Times More Effectively with Continued Maximum Dose of Tirzepatide, Study Finds

May 12, 2026

Immune Protein Identified as Potential Target to Slow Parkinson’s Disease Progression

May 12, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    842 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    728 shares
    Share 290 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Mayo Clinic to Undergo Leadership Transition, Honoring Dr. Gianrico Farrugia’s Transformational Impact

Study Finds Sustained Weight Loss Possible by Transitioning from Injectable Obesity Drugs to Daily Oral Orforglipron (ATTAIN-MAINTAIN)

Weight Loss Maintained Seven Times More Effectively with Continued Maximum Dose of Tirzepatide, Study Finds

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.